Bisphosphonate osteonecrosis: a protocol for surgical management

British Journal of Oral and Maxillofacial Surgery

Volumn 47, Issue 4, 2009, Pages 294-297

  Markose, George ^a   Mackenzie, Fiona R ^a   Currie, W J R ^a   Hislop, W S ^a  

^a CROSSHOUSE HOSPITAL   (United Kingdom)

Author keywords

Bisphosphonate; Osteonecrosis; Surgical management

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CLINDAMYCIN; PAMIDRONIC ACID; ZOLEDRONIC ACID;

ADULT; AGED; ALVEOLAR BONE; ARTICLE; BONE PAIN; CLINICAL ARTICLE; FEMALE; HUMAN; INFECTION; JAW OSTEONECROSIS; MALE; MOUTH HYGIENE; TOOTH EXTRACTION;

AGED; ALVEOLAR BONE LOSS; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAW DISEASES; MALE; MANDIBULAR DISEASES; MIDDLE AGED; OSTEONECROSIS; TOOTH EXTRACTION; TREATMENT OUTCOME;

EID: 67349084055     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2009.01.007     Document Type: Article

References (14)

1. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65:369-76.
2. Hughes D.E., MacDonald B.R., Russell R.G., and Gowen M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest 83 (1989) 1930-1935
3. Hughes D.E., Wright K.R., Uy H.L., Sasaki A., Roneda T., Roodman G.D., et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10 (1995) 1478-1487
4. Murakami H., Takahashi N., Sasaki T., Udagawa N., Tanaka S., Nakamura I., et al. A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders. Bone 17 (1995) 137-144
5. Kapitola J., Zak J., Lacinova Z., and Justova V. Effect of growth hormone and pamidronate on bone blood flow, bone mineral and IGF-I levels in the rat. Physiol Res 49 Suppl. 1 (2000) s101-s106
6. Kapitola J., and Zak J. Effect of pamidronate on bone blood flow in oophorectomized rats. Physiol Res 47 (1998) 237-240
7. Fournier P., Boissier S., Filleur S., Guglielmi J., Cabon F., Colombel M., et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 62 (2002) 6538-6544
8. Wood J., Bonjean K., Ruetz S., Bellahcene A., Devy L., Foidart J.M., et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302 (2002) 1055-1061
9. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115-1117
10. Ruggiero S.L., Fantasia J., and Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surge Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 433-441
11. Freiberger J., Padilla-Burgos R., Chhoeu A.H., Kraft K.H., Boneta O., Moon R.E., et al. Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series. J Oral Maxillofac Surg 65 (2007) 1321-1327
12. Agrillo A., Petrucci M.T., Tedaldi M., Murtazza M.C., Marino S.M., Gallucci C., et al. New therapeutic protocol in the treatment of avascular necrosis of the jaws. J Craniofac Surg 17 (2006) 1080-1083
13. LongobardiG, Boniello R., Gasparini G., Pagano I., and Pelo S. Surgical therapy for osteonecrotic lesions of the jaws in patients in therapy with bisphosphonates. J Craniofac Surg 18 (2007) 1012-1017
14. Magopoulos C., Karakinaris G., Telioudis Z., Vahtsevanos K., Dimitrakopoulos I., Antoniadis K., et al. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol 28 (2007) 158-163